Demographic and clinical characteristics
| Variable | Triple positivity (N=19) | No triple positivity (N=55) | P value |
|---|---|---|---|
| Age | 41.7±10.3 | 44±13.5 | NS |
| Female gender | 17 (89.5) | 44 (80.0) | NS |
| Caucasian | 14 (73.7) | 37 (67.3) | NS |
| Time first manifestation (mo) | 143 (97–240) | 124.7 (67–176) | NS |
| Time diagnosis (mo) | 55 (26–134) | 64 (43–103) | NS |
| Criteria manifestations* | |||
| Thrombotic | 17 (89.5) | 45 (81.8) | NS |
| Arterial | 10 (52.6) | 17 (30.3) | NS |
| Venous | 10 (52.6) | 35 (63.6) | NS |
| Abortion 3+ | 3 (20.0)† | 1 (2.8)†† | p=0.043 |
| Thrombotic + obstetric | 10 (58.8)‡ | 10 (23.8)‡‡ | p=0.008 |
| Non criteria | |||
| Livedo | 9 (47.4) | 11 (20.0) | p=0.023 |
| Thrombocytopenia | 7 (36.8) | 10 (18.2) | NS |
| Valvulopathy** | 2 (10.5) | 6 (10.9) | NS |
| Raynaud phenomenon | 7 (36.8) | 12 (21.8) | NS |
| Leg ulcers | 1 (5.3) | 4 (7.3) | NS |
| Nephropathy | 0 | 1 (1.8) | NS |
| Migraine | 8 (42.1) | 25 (45.5) | NS |
*N=67; **N=49; †N=15; ††N=36; ‡N=17; ‡‡N=42. Mo = months. NS = not significant, NA = not applicable. Values showed as N (%) for categorical variables, Mean ± SD for normal distribution and Median (interquartil range) for asymmetrical distribution.